The Small Business Administration’s Federal and State Technology (FAST) Partnership Program is designed to support programs that advance innovative, technology-driven small businesses. The Arizona Commerce Authority has partnered with the Small Business Administration (SBA) to facilitate the FAST program in Arizona.Continue reading
Tucson, Ariz. (February 1, 2023) – The PGA TOUR Champions, the Tucson Conquistadores, the First Tee Tucson, and Exact Sciences, the maker of Cologuard®, announced today that the Madison, Wisconsin-based company will now be the presenting sponsor of the Cologuard Classic. The announcement also extends Cologuard’s title sponsorship through the 2027 season. The 2023 Cologuard Classic by Exact Sciences will take place at the Omni Tucson National Resort from February 27th through March 5th and will have a $2.2 million purse, with $330,000 to the winner.Continue reading
TUCSON, AZ / ACESSWIRE / January 31, 2023 / Aqualung Therapeutics, an early stage immunotherapeutics company with a novel anti-inflammatory and anti-fibrotic therapeutic platform for life-threatening unchecked inflammation/fibrosis, today announced that it has engaged Novotech, a leading Asia Pacific centered, full-service contract research organization (“CRO”) in the Asia-Pacific, United States and Europe, for its upcoming Phase 2a PUERTA clinical trial utilizing the humanized ALT-100 mAb. Aqualung currently plans to initiate its Phase 2a clinical trial in Australia starting in Q2 2023. The study will enroll moderate/severe ARDS subjects in hospital locations in Australia as well at multiple sites in the United States.Continue reading
A component of the AZAdvances Talent Program, AZAdvances internships are designed to support Arizona students as they explore career paths in health and life sciences. Internships are created in partnership with AZBio member organizations and are supported though grants and donations to the Opportunity Through Entrepreneurship Foundation’s benefiting the AZAdvances initiative.Continue reading
The Post-COVID world has an increased population suffering from sleep issues, and good sleep is the basis to good health. An insomnia intervention which is natural and non-invasive can be an important aspect to achieve improved health in a post-COVID world.Continue reading
In 2022, Arizona established the Arizona Health Innovation Trust Fund as a vehicle to drive the creation of health innovations that can improve quality of life for people of Arizona and increase opportunities for the high quality jobs Arizona Health Innovators create. The FY2023 appropriation was $100,000 to allow the initial set up of the fund. In 2023, two bills at the Arizona Legislature (HB2253 and SB1084) propose a $200 million dollar one-time investment into the Arizona Health Innovation Trust Fund.Continue reading
Launched in 2022, the Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients. TRxA is now accepting applications for its 2023 funding cycle.Continue reading
TUCSON, Ariz., Jan. 25, 2023 — Critical Path Institute (C-Path) today announced that the European Medicines Agency (EMA) has issued a letter of support for the Duchenne Regulatory Science Consortium’s (D-RSC) Model-based Clinical Trial Simulation Platform for Duchenne Muscular Dystrophy (DMD).Continue reading
WASHINGTON, D.C. – In a letter to the White House, the Advanced Medical Technology Association (AdvaMed) outlined four key priorities in pending regulations for facilities sterilizing medical devices with ethylene oxide (EtO).Continue reading